Genetics and Genomics

Genetics company sells MassARRAY technology to the University of Hong Kong

Published in Drug Week, August 1st, 2003

SEQUENOM, Inc., (SQNM) announced that it has sold a MassARRAY system to the Genome Research Center at the University of Hong Kong for their contribution to the International HapMap Project.

The HapMap Project is a $100 million public-private effort launched to construct a detailed map of genetic variation in the human genome. The University of Hong Kong joins several other prominent institutions already using MassARRAY technology for the HapMap Project, including The Whitehead Institute which operates four MassARRAY systems and received a grant of $8.4 million to perform approximately 71 million individual MALDI-TOF genotypes for the HapMap Project.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2003-08-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry